|FMI -- USA Stock|| |
USD 136.88 0.07 0.05%
Mr. Jason Ryan serves as a Chief Financial Officer, Principal Financial Officer, Principal Accounting officer of the Company. Mr. Ryan has served as our Chief Financial Officer since March 2015, as our Senior Vice President, Finance from January 2014 to March 2015 and as our Vice President, Finance from March 2012 to January 2014. He previously served as our Senior Director, Finance from May 2011 to March 2012. Prior to joining us, Mr. Ryan led the finance and strategic planning functions of Taligen Therapeutics, Inc., which was acquired by Alexion Pharmaceuticals, Inc., from May 2009 to April 2011, Codon Devices Inc. from May 2007 to May 2009 and Genomics Collaborative, Inc., which was acquired by SeraCare Life Sciences, Inc., from September 1998 to September 2004. He began his career at Deloitte Touche
Age: 42 CFO Since 2015 CPA
Ryan holds a B.S. in economics from Bates College and an M.B.A. from Babson College, and earned a C.P.A. in Massachusetts.